ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -25 مورد

Sulconazole: Drug information

Sulconazole: Drug information
2025© UpToDate, Inc. and its affiliates and/or licensors. All Rights Reserved.
For additional information see "Sulconazole: Patient drug information"

For abbreviations, symbols, and age group definitions show table
Brand Names: US
  • Exelderm
Pharmacologic Category
  • Antifungal Agent, Imidazole Derivative;
  • Antifungal Agent, Topical
Dosing: Adult
Tinea infection

Tinea infection:

Tinea corporis/tinea cruris : Topical: Cream 1%, solution 1%: Apply to affected and surrounding area(s) 1 to 2 times daily until clinical resolution, typically 1 to 3 weeks (Ref).

Tinea pedis (labeled use)/tinea manuum (off-label use): Topical: Cream 1%: Apply to affected and surrounding area(s) twice daily until 1 week after clinical resolution, typically for 4 weeks total (Ref).

Tinea versicolor (pityriasis versicolor): Topical: Cream 1%, solution 1%: Apply a small amount to affected area(s) and surrounding skin once or twice daily for 3 weeks (Ref).

Dosage adjustment for concomitant therapy: Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.

Dosing: Kidney Impairment: Adult

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Liver Impairment: Adult

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Older Adult

Refer to adult dosing.

Adverse Reactions

The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.

1% to 10%: Dermatologic: Burning sensation of skin (≤3%), erythema of skin (1%), pruritus (1% to 3%), stinging of the skin (≤3%)

Contraindications

Hypersensitivity to sulconazole or any component of the formulation

Warnings/Precautions

Concerns related to adverse effects:

• Irritation: Discontinue if sensitivity or irritation occurs.

Other warnings/precautions:

• Appropriate use: For topical use only; avoid contact with eyes.

Dosage Forms: US

Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

Cream, External, as nitrate:

Exelderm: 1% (60 g) [contains cetyl alcohol, propylene glycol]

Generic: 1% (60 g)

Solution, External, as nitrate:

Exelderm: 1% (30 mL) [contains propylene glycol]

Generic: 1% (30 mL)

Generic Equivalent Available: US

Yes

Pricing: US

Cream (Exelderm External)

1% (per gram): $14.74

Cream (Sulconazole Nitrate External)

1% (per gram): $10.65

Solution (Exelderm External)

1% (per mL): $19.22

Solution (Sulconazole Nitrate External)

1% (per mL): $13.89

Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

Administration: Adult

For external use only; avoid contact with the eyes. Apply a small amount and gently massage into affected and surrounding skin areas.

Use: Labeled Indications

Fungal infections:

Cream: Treatment of tinea pedis (athlete's foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; treatment of tinea versicolor (pityriasis versicolor).

Solution: Treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; treatment of tinea versicolor.

Limitations of use: Effectiveness has not been proven in tinea pedis (athlete's foot).

Use: Off-Label: Adult

Tinea manuum

Metabolism/Transport Effects

None known.

Drug Interactions

There are no known significant interactions.

Pregnancy Considerations

Adverse events have been observed in animal reproduction studies with large doses administered orally. Systemic absorption is limited following topical administration.

Breastfeeding Considerations

It is not known if sulconazole is present in breast milk. The manufacturer recommends that caution be exercised when administering sulconazole to breastfeeding women.

Mechanism of Action

Substituted imidazole derivative which inhibits metabolic reactions necessary for the synthesis of ergosterol, an essential membrane component. The end result is usually fungistatic; however, sulconazole may act as a fungicide in Candida albicans and Candida parapsilosis during certain growth phases.

Pharmacokinetics (Adult Data Unless Noted)

Absorption: Topical: ~8.7% to 11% percutaneously (Franz 1988)

Excretion: Primarily urine

Brand Names: International
International Brand Names by Country
For country code abbreviations (show table)

  • (AR) Argentina: Antifungal;
  • (BD) Bangladesh: Sulderm;
  • (BE) Belgium: Myk-1;
  • (DO) Dominican Republic: Fulcol;
  • (EC) Ecuador: Exelderm | Fulcol;
  • (EG) Egypt: Sulco fung;
  • (FR) France: Myk;
  • (GB) United Kingdom: Exelderm | Exelderm znc;
  • (GR) Greece: Suldicyn;
  • (ID) Indonesia: Exelderm;
  • (IE) Ireland: Exelderm;
  • (JP) Japan: Excive | Excive tanabe | Exelderm;
  • (KR) Korea, Republic of: Exelderm;
  • (LU) Luxembourg: Myk-1;
  • (MA) Morocco: Myk;
  • (NL) Netherlands: Myk-1;
  • (PH) Philippines: Exelderm;
  • (PK) Pakistan: Exelderm;
  • (PR) Puerto Rico: Exelderm;
  • (TH) Thailand: Exelderm;
  • (TN) Tunisia: Myk;
  • (TR) Turkey: Exelderm;
  • (TW) Taiwan: Exelderm
  1. Exelderm (sulconazole) 1% cream [prescribing information]. Scottsdale, AZ: Journey Medical Corp; March 2021.
  2. Exelderm (sulconazole nitrate, USP) 1% solution [prescribing information]. Scottsdale, AZ: Journey Medical Corp; February 2019.
  3. Franz TJ, Lehman P, Percutaneous absorption of sulconazole nitrate in humans. J Pharm Sci. 1988;77 (6): 489-491. [PubMed 3171926]
  4. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed August 24, 2021.
  5. Refer to manufacturer's labeling.
  6. Tanenbaum L, Anderson C, Rosenberg MJ, Akers W. 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study. Arch Dermatol. 1984;120(2):216-219. [PubMed 6364994]
  7. Tham SN. Treatment of pityriasis versicolor: comparison of sulconazole nitrate 1% solution and clotrimazole 1 % solution. Australas J Dermatol. 1987;28(3):123-125. doi:10.1111/j.1440-0960.1987.tb00351.x [PubMed 3332758]
  8. van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2015;172(3):616-641. doi:10.1111/bjd.13441 [PubMed 25294700]
  9. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095-2102. [PubMed 12046779]
Topic 9956 Version 155.0